Results 111 to 120 of about 2,663 (168)

"Phenoconversion in adult patients with b-thalassemia"

Patients with clinically significant forms of β-thalassemia have been historically classified as having a β-thalassemia major or β-thalassemia intermedia phenotype, with the first primarily referring to patients who present with severe anemia during early childhood and require lifelong transfusion therapy and the latter relating to patients who present
Musallam KM, Barella S, Origa R, Ferrero GBm Lisi R, Pasanisi A, Long F, Gianesin B, Pinto V, Sciortino R, Roberti D, De Franceschi L, Culcasi M, Forni G   +12 more
openaire   +1 more source

Nigro-striatal deficits capture phenoconversion risk in isolated REM sleep behavior disorder

Isolated rapid eye movement sleep behavior disorder (iRBD) is characterized by nigro-striatal deficits, comprising dopaminergic denervation of the striatum and loss of dopaminergic cells in the substantia nigra (SN), that may herald phenoconversion to ...
Aurélie Kas, Romain Valabrègue, Stéphane Lehéricy, Jean-Cristophe Corvol, Nicolas Villain, Alexis Baron, Marie Vidailhet, Graziella Mangone, Isabelle Arnulf, Martin Johansson, Pauline Dodet, Vineeth Radhakrishnan, Rahul Gaurav, Anthony Ruze   +13 more
core   +1 more source

Phenoconversion of Cytochrome P450 2D6

The Journal of Clinical Psychiatry, 2013
Berm, Elizabeth J J, Risselada, Arne J, Mulder, Hans, Hak, Eelko, Wilffert, Bob   +4 more
openaire   +4 more sources

Gray matter alterations and their atlas-based spatial associations with neurotransmitter distributions in isolated REM sleep behavior disorder. [PDF]

Sleep Breath
Byun JI, Song H, Shin JH, Kim HJ, Shin WC, Sohn CH, Jung KY.   +6 more
europepmc   +1 more source

Clinical markers of disease progression in the prodromal to overt alpha-synucleinopathy continuum. [PDF]

Brain
Roascio M, Antelmi E, Baldelli L, Biscarini F, Bonanni E, Brunetti V, Capriglia E, Geromino C, Casoni F, Cirillo F, Della Marca G, Di Laudo F, Ferini-Strambi L, Fernandes M, Figorilli M, Galbiati A, Gigli GL, Guarnieri B, Hoxhaj D, Lanza G, Liguori C, Maestri Tassoni M, Maio S, Malomo G, Marelli S, Mattioli P, Mulas M, Orso B, Pardini M, Plazzi G, Provini F, Pellitteri G, Puligheddu M, Terzaghi M, Pelletier A, Postuma RB, Arnulfo G, Arnaldi D, FARPRESTO consortium.   +38 more
europepmc   +1 more source

Pure Autonomic Failure and Central Synucleinopathy Risk. [PDF]

JAMA Neurol
Beach P, Freeman R.
europepmc   +1 more source

Digital biomarkers derived from wearable and portable devices in prodromal Parkinson's disease and at-risk populations: a scoping review. [PDF]

Front Aging Neurosci
Yu T, Wang Q, Pan M, Xiong Y, Hu S, Deng Y, Kuang L, Liu H.   +7 more
europepmc   +1 more source

Reply to: "Idebenone in Rapid Eye Movement Sleep Behavioral Disorder for Parkinson's Disease Prevention". [PDF]

Mov Disord
Li Y, Liu J.
europepmc   +1 more source

Mild cognitive impairment in presymptomatic amyotrophic lateral sclerosis. [PDF]

J Neurol
McHutchison C, Wuu J, Cosentino S, Saldana R, Vadella E, Benacerraf A, McBane K, Gonzalez AS, Stark JH, Li Y, Abrahams S, Benatar M.   +11 more
europepmc   +1 more source

Idebenone in Rapid Eye Movement Sleep Behavioral Disorder for Parkinson's Disease Prevention. [PDF]

Mov Disord
Tambasco N, Nigro P.
europepmc   +1 more source